Published in Am J Alzheimers Dis Other Demen on February 07, 2002
Young onset dementia. Postgrad Med J (2004) 1.20
Effect of pioglitazone treatment in a patient with secondary multiple sclerosis. J Neuroinflammation (2004) 1.00
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. Ther Adv Neurol Disord (2011) 0.94
Exercise in multiple sclerosis -- an integral component of disease management. EPMA J (2011) 0.87
Depression, disability and cognitive impairment in multiple sclerosis: a cross sectional Italian study. Neurol Sci (2011) 0.85
Working memory deficits in multiple sclerosis: a controlled study with auditory P600 correlates. J Neurol Neurosurg Psychiatry (2003) 0.78
Increased risk of dementia among chronic osteomyelitis patients. Eur J Clin Microbiol Infect Dis (2014) 0.78
Ocular motor measures of cognitive dysfunction in multiple sclerosis II: working memory. J Neurol (2015) 0.77
Influences on cognition by immunosuppression and immunomodulation in multiple sclerosis. J Neurol (2007) 0.76
Prospective memory and chronic heart failure. BMC Cardiovasc Disord (2013) 0.75
Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus. Clin Immunol (2008) 0.96
An extended genome scan in 442 Canadian multiple sclerosis-affected sibships: a report from the Canadian Collaborative Study Group. Hum Mol Genet (2004) 0.96
Variations in mitochondrial DNA copy numbers in MS brains. J Mol Neurosci (2008) 0.90
Involvement of beta-chemokines in the development of inflammatory demyelination. J Neuroinflammation (2005) 0.88
Haplotypes within genes of beta-chemokines in 17q11 are associated with multiple sclerosis: a second phase study. Hum Genet (2005) 0.88
Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects. J Neuroimmunol (2012) 0.88
CCL genes in multiple sclerosis and systemic lupus erythematosus. J Neuroimmunol (2008) 0.86
Genetic variants of Complex I in multiple sclerosis. J Neurol Sci (2005) 0.85
5-HT(1B) receptors play a prominent role in the proliferation of T-lymphocytes. J Neuroimmunol (2006) 0.85
Association of haplotypes in the beta-chemokine locus with multiple sclerosis. Eur J Hum Genet (2005) 0.85
CD45 (PTPRC) as a candidate gene in multiple sclerosis. Mult Scler (2004) 0.85
Autoantibodies and neurodegeneration in multiple sclerosis. Lab Invest (2008) 0.83
MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis. J Neurol (2009) 0.82
Molecular heterogeneity of glioblastoma and its clinical relevance. Pathol Oncol Res (2014) 0.82
Lack of mitochondrial DNA deletions in lesions of multiple sclerosis. Neuromolecular Med (2008) 0.81
An international registry for neurodegeneration with brain iron accumulation. Orphanet J Rare Dis (2012) 0.80
Does obstetric brachial plexus injury influence speech dominance? Ann Neurol (2009) 0.80
External ophthalmoplegia with severe progressive multiorgan involvement associated with the mtDNA A3243G mutation. J Neurol Sci (2002) 0.80
Hormonal and biochemical parameters correlated with bone densitometric markers in prepubertal Hungarian children. Bone (2013) 0.80
Genetics of multiple sclerosis: determinants of autoimmunity and neurodegeneration. Autoimmunity (2002) 0.79
Analyses of a MS-associated haplotype encompassing the CCL3 gene. J Neuroimmunol (2006) 0.78
Pathogenesis of multiple sclerosis: what can we learn from the cuprizone model. Methods Mol Biol (2012) 0.77
Bcl-2 and its homologues in the brain of patients with multiple sclerosis. Mult Scler (2004) 0.76
Studies of mitochondrial DNA in Devic's disease revealed no pathogenic mutations, but polymorphisms also found in association with multiple sclerosis. Ann Neurol (2002) 0.76
Do old HLA and mitochondrial DNA variants associate with demyelination types in young patients? Neurology (2011) 0.75
A rational design approach for developing immunomodulators based on CD4 and CD8. Biotechnol Genet Eng Rev (2002) 0.75
ASSOCIATION OF TEMPORAL LOBE INFLAMMATORY LEUKOENCEPHALOPATHY WITH TWO B CELL MALIGNANCIES. Ideggyogy Sz (2014) 0.75